Ocuphire Pharma
OCUP
$1.68
Share price
0.00%
Change (1 day)
-58.21%
Change (1 year)
Categories
Ocuphire Pharma (OCUP) - P/B ratio
P/B ratio as of June 2024 : 0.9625
According to Ocuphire Pharma's latest financial reports the company has a price-to-book ratio of 0.9625.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Ocuphire Pharma - P/B ratio (from 2020 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 1.37 | -14.05% |
| 2022-12-31 | 1.59 | -49.78% |
| 2021-12-31 | 3.16 | -160.32% |
| 2020-12-31 | -5.24 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 0.7844 | -18.50% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 3.48 | 261.08% | 🇺🇸 USA |